Pharmaceutical company, AstraZeneca, have come under fire after paying its new chief executive £6.5m for three months work last year.
The Local Authority Pension fund Forum (LAPFF), one of Britain’s largest shareholder groups has called on its members to vote against AstraZeneca’s remuneration report at the company’s annual meeting next week. (Más)
Con el recuerdo aun fresco de la indemnización por "salida" de Daniel Vasella (Novartis) ahora nos sorprende AstraZeneca con el "Golden Hello" a Pascal Soirot (ex Roche)
Ver también:
No hay comentarios:
Publicar un comentario